Compare AANJANEYA LIFECARE with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS DR. REDDYS LAB DR. DATSONS LABS/
DR. REDDYS LAB
 
P/E (TTM) x -10.9 21.5 - View Chart
P/BV x 0.2 3.2 5.0% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 DR. DATSONS LABS   DR. REDDYS LAB
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
DR. REDDYS LAB
Mar-19
DR. DATSONS LABS/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1262,875 4.4%   
Low Rs311,888 1.6%   
Sales per share (Unadj.) Rs133.0930.2 14.3%  
Earnings per share (Unadj.) Rs0.2117.4 0.1%  
Cash flow per share (Unadj.) Rs6.6185.8 3.6%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8844.4 15.3%  
Shares outstanding (eoy) m31.66166.07 19.1%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.62.6 23.0%   
Avg P/E ratio x516.120.3 2,544.8%  
P/CF ratio (eoy) x11.812.8 92.4%  
Price / Book Value ratio x0.62.8 21.5%  
Dividend payout %017.0 0.0%   
Avg Mkt Cap Rs m2,477395,496 0.6%   
No. of employees `000NA22.0 0.0%   
Total wages/salary Rs m5633,562 0.2%   
Avg. sales/employee Rs ThNM7,032.8-  
Avg. wages/employee Rs ThNM1,527.9-  
Avg. net profit/employee Rs ThNM887.7-  
INCOME DATA
Net Sales Rs m4,211154,482 2.7%  
Other income Rs m793,375 2.3%   
Total revenues Rs m4,289157,857 2.7%   
Gross profit Rs m56931,782 1.8%  
Depreciation Rs m20411,348 1.8%   
Interest Rs m430889 48.4%   
Profit before tax Rs m1322,920 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2438 -0.4%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m63,858 0.2%   
Profit after tax Rs m519,500 0.0%  
Gross profit margin %13.520.6 65.6%  
Effective tax rate %48.016.8 285.4%   
Net profit margin %0.112.6 0.9%  
BALANCE SHEET DATA
Current assets Rs m6,852111,101 6.2%   
Current liabilities Rs m6,71158,973 11.4%   
Net working cap to sales %3.333.7 9.9%  
Current ratio x1.01.9 54.2%  
Inventory Days Days16179 202.7%  
Debtors Days Days31894 338.1%  
Net fixed assets Rs m3,673101,245 3.6%   
Share capital Rs m317830 38.1%   
"Free" reserves Rs m3,761139,406 2.7%   
Net worth Rs m4,078140,236 2.9%   
Long term debt Rs m1,67122,000 7.6%   
Total assets Rs m12,633224,656 5.6%  
Interest coverage x1.026.8 3.8%   
Debt to equity ratio x0.40.2 261.2%  
Sales to assets ratio x0.30.7 48.5%   
Return on assets %3.49.1 37.9%  
Return on equity %0.113.9 0.8%  
Return on capital %7.714.9 51.3%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96488,673 1.1%   
Fx outflow Rs m60719,104 3.2%   
Net fx Rs m35769,569 0.5%   
CASH FLOW
From Operations Rs m1,34528,704 4.7%  
From Investments Rs m-2,256-7,727 29.2%  
From Financial Activity Rs m-1,200-21,326 5.6%  
Net Cashflow Rs m-2,111-314 672.2%  

Share Holding

Indian Promoters % 4.5 25.5 17.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.4 -  
FIIs % 1.4 35.3 3.8%  
ADR/GDR % 0.0 18.5 -  
Free float % 94.1 15.3 615.0%  
Shareholders   20,807 75,885 27.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   PROCTER & GAMBLE HEALTH  IPCA LABS  ASTRAZENECA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS